Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Common Equity (2019 - 2025)

Historic Common Equity for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $60.0 million.

  • Pulmonx's Common Equity fell 3608.41% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year decrease of 3608.41%. This contributed to the annual value of $85.8 million for FY2024, which is 2747.41% down from last year.
  • Pulmonx's Common Equity amounted to $60.0 million in Q3 2025, which was down 3608.41% from $69.1 million recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Common Equity peaked at $216.1 million during Q1 2021, and registered a low of $60.0 million during Q3 2025.
  • Moreover, its 5-year median value for Common Equity was $134.0 million (2023), whereas its average is $137.5 million.
  • In the last 5 years, Pulmonx's Common Equity soared by 21139.24% in 2021 and then tumbled by 3608.41% in 2025.
  • Pulmonx's Common Equity (Quarter) stood at $193.2 million in 2021, then fell by 20.3% to $154.0 million in 2022, then fell by 23.18% to $118.3 million in 2023, then decreased by 27.47% to $85.8 million in 2024, then plummeted by 30.04% to $60.0 million in 2025.
  • Its last three reported values are $60.0 million in Q3 2025, $69.1 million for Q2 2025, and $77.7 million during Q1 2025.